XENPOZYME is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genzyme Corporation. The primary component is Olipudase Alfa.
Product ID | 58468-0050_090d024d-27b6-4b40-b628-a49d58ddfca4 |
NDC | 58468-0050 |
Product Type | Human Prescription Drug |
Proprietary Name | XENPOZYME |
Generic Name | Olipudase Alfa-rpcp |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-08-31 |
Marketing Category | BLA / |
Application Number | BLA761261 |
Labeler Name | Genzyme Corporation |
Substance Name | OLIPUDASE ALFA |
Active Ingredient Strength | 20 mg/5.1mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-08-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XENPOZYME 90407808 not registered Live/Pending |
Genzyme Corporation 2020-12-23 |
XENPOZYME 88330513 not registered Live/Pending |
Genzyme Corporation 2019-03-07 |
XENPOZYME 86756168 not registered Dead/Abandoned |
Genzyme Corporation 2015-09-14 |